Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

LymphomaAutologous Hematopoietic Stem Cell Transplantation

Interventions

DRUG

Improved BEAM regimen

Mitoxantrone hydrochloride liposome, carmostine, etoposide and cytarabine will be used as conditioning regimen for ASCT in the lymphoma patients.

Trial Locations (1)

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors

lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT05681403 - Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma | Biotech Hunter | Biotech Hunter